Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies

Journal Article · · Cell Reports
 [1];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [3];  [2];  [4];  [2]
  1. Fred Hutchinson Cancer Research Center, Seattle, WA (United States). Vaccines and Infectious Diseases Division; OSTI
  2. Fred Hutchinson Cancer Research Center, Seattle, WA (United States). Vaccines and Infectious Diseases Division
  3. Fred Hutchinson Cancer Research Center, Seattle, WA (United States). Vaccines and Infectious Diseases Division; Univ. of Washington, Seattle, WA (United States). Dept. of Global Health; Univ. of Washington, Seattle, WA (United States). Dept. of Immunology
  4. Fred Hutchinson Cancer Research Center, Seattle, WA (United States). Vaccines and Infectious Diseases Division; Univ. of Washington, Seattle, WA (United States). Dept. of Global Health
An effective HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs). Broad and potent VRC01-class bNAbs have been isolated from multiple infected individuals, suggesting that they could be reproducibly elicited by vaccination. Several HIV-1 envelope-derived germline-targeting immunogens have been designed to engage naive VRC01-class precursor B cells. However, they also present off-target epitopes that could hinder development of VRC01-class bNAbs. We characterize a panel of anti-idiotypic monoclonal antibodies (ai-mAbs) raised against inferred-germline (iGL) VRC01-class antibodies. By leveraging binding, structural, and B cell sorting data, we engineered a bispecific molecule derived from two aimAbs; one specific for VRC01-class heavy chains and one specific for VRC01-class light chains. The bispecific molecule preferentially activates iGL-VRC01 B cells in vitro and induces specific antibody responses in a murine adoptive transfer model with a diverse polyclonal B cell repertoire. This molecule represents an alternative non-envelope-derived germline-targeting immunogen that can selectively activate VRC01-class precursors in vivo.
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-05CH11231; AC02-76SF00515
OSTI ID:
1816187
Journal Information:
Cell Reports, Journal Name: Cell Reports Journal Issue: 5 Vol. 35; ISSN 2211-1247
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (85)

[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization journal March 2013
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy journal February 2014
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors journal June 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice journal June 2015
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires journal September 2016
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies journal September 2016
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses journal June 2018
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies journal August 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition journal April 2020
A Blueprint for HIV Vaccine Discovery journal October 2012
When designing vaccines, consider the starting material: the human B cell repertoire journal August 2018
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies journal August 2013
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers journal May 2014
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth journal November 2016
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens journal January 2018
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus journal April 2018
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure journal May 2018
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan journal July 2019
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo journal September 2020
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors journal October 2020
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning journal January 2008
Cloning and expression of murine Ig genes from single B cells journal October 2009
Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination journal February 2018
Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys journal February 1999
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection journal February 2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies journal February 2000
Fc receptor but not complement binding is important in antibody protection against HIV journal September 2007
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals journal March 2009
Antibody-based protection against HIV infection by vectored immunoprophylaxis journal November 2011
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody journal September 2012
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies journal March 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface journal September 2014
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice journal February 2016
Antibody responses to envelope glycoproteins in HIV-1 infection journal May 2015
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques journal June 2009
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission journal February 2014
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site journal September 2016
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies journal February 2019
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses journal February 2019
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin journal February 2012
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 journal June 2012
A mouse model for HIV-1 entry journal September 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo journal October 2012
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody journal March 2013
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires journal April 2016
Anti–HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity journal April 2018
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models journal September 2020
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies journal March 2013
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo journal August 2017
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes journal July 2019
Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses journal July 2019
Neutralizing Antibodies Administered Before, but Not After, Virulent SHIV Prevent Infection in Macaques journal August 1998
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis journal May 2008
Phaser crystallographic software journal July 2007
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Towards automated crystallographic structure refinement with phenix.refine journal March 2012
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target journal September 2009
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 journal July 2010
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins journal July 2011
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing journal August 2011
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design journal October 2011
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization journal May 2013
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors journal March 2013
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies journal December 2014
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen journal March 2016
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice journal September 2016
Structural basis of a shared antibody response to SARS-CoV-2 journal July 2020
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen journal July 2018
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection journal March 2015
Antibody and Antiretroviral Preexposure Prophylaxis Prevent Cervicovaginal HIV-1 Infection in a Transgenic Mouse Model journal May 2013
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D journal December 2013
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design journal February 2012
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies journal January 1999
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro journal September 2001
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design journal May 2016
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals journal January 2010
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs journal January 2013
Structural basis for germline antibody recognition of HIV-1 immunogens journal March 2016
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core journal November 2018

Similar Records

HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Journal Article · Thu Mar 24 20:00:00 EDT 2016 · Science · OSTI ID:1345050

Structural basis for germline antibody recognition of HIV-1 immunogens
Journal Article · Sun Mar 20 20:00:00 EDT 2016 · eLife · OSTI ID:1628850

The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
Journal Article · Tue Jul 03 20:00:00 EDT 2018 · Science Translational Medicine · OSTI ID:1499777